JAK-STATopathies | Tuesday Lunch with RITA
This Tuedsay lunch with RITA session focused on JAK-STATopathies, a group of rare immune dysregulation disorders caused by pathogenic variants affecting the JAK-STAT signaling pathway. These complex conditions are associated with a broad and often overlapping clinical spectrum, including autoimmunity, autoinflammation, immunodeficiency, lymphoproliferation, and increased susceptibility to infections. With disease onset ranging from early childhood to adulthood, timely recognition and appropriate management are essential. The speakers highlighted key clinical features, diagnostic approaches, and emerging therapeutic strategies. Speakers: Dr Marco Fischer Dr Peter Olbrich Discussion moderated by: Dr Carsten Speckmann Hosted by: Dr Maud Tusseau

IgA vasculitis | Tuesday Lunch with RITA & EUVAS

RespiriTB Stakeholder Webinar 2026: Advancing TB Innovation Through Collaboration (June 23, 2026)

Why cancer patients are flying to China for treatment - Asia Specific podcast, BBC World Service

Spine Surgeon Drowns for 30 Minutes —Comes Back With a List

How to understand native speakers when they talk quickly: Live English Class

What You Need To Know About Hell | #Jahannam Webinar by Dr. Omar Suleiman

The Ceasefire War | feat. Lt. Col. (Ret.) Conricus, Behnam Ben Taleblu, and RADM (Ret.) Montgomery

Catholic Mass 101: Learn Every Part of the Mass and What It Means (w/ Fr. Mike Schmitz)

Is Russia Actually Losing?

How to increase your vocabulary: Live English Class

I Investigated The World's Skinniest vs Fattest City

The Most Famous (TV) Doctor Of All Time | Noah Wyle

Medical breakthroughs and health stories | 60 Minutes Marathon

Something is jamming GPS over Europe. Here's what we found

OUTSIDER POLITIC #5. Traian Băsescu: „Nicușor Dan e un președinte care nu poate servi țara”

How to Start Coding | Programming for Beginners | Learn Coding | Intellipaat

Statins Might Be Finished After This Breakthrough

Why Purpose Is The Only Path To Fulfillment

The French Do Not Care About Work

